Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 4Lymphoma 4Prostatic Neoplasms 3Myelodysplastic Syndromes 3Leukemia 3Hematologic Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma, B-Cell 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Colonic Neoplasms 2Cardiotoxicity 2Carcinoma in Situ 2Burkitt Lymphoma 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Sleep Initiation and Maintenance Disorders 1Recurrence 1Philadelphia Chromosome 1Peritoneal Neoplasms 1Papillomavirus Infections 1

Interventions

Carboplatin 5Paclitaxel 4pembrolizumab 3Educational Status 3niraparib 2anlotinib 2Therapeutic Touch 2Pemetrexed 2Palliative Care 2Nivolumab 2Methods 2Gemcitabine 2Early Intervention, Educational 2Bevacizumab 2temsirolimus 1rucaparib 1relacorilant 1olaparib 1nintedanib 1nilotinib 1liposomal doxorubicin 1lenvatinib 1fosaprepitant 1atezolizumab 1argatroban 1Watchful Waiting 1Transurethral Resection of Prostate 1Topotecan 1Thrombopoietin 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Genital Neoplasms, Female × Electrocardiography × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡